Login

Insider Transactions

What CONSTELLATION PHARMACEUTICALS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 0

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Goldsmith Mark A Director Jul 15 Disposition to Issuer · D −89,857 — — 0
Audia James E Director Jul 15 Disposition to Issuer · D −25,434 — — 0
Raythatha Jigar See Remarks Jul 15 Disposition to Issuer · D −14,961 — — 0
Goldsmith Mark A Director Mar 04 Exercise / conversion · M +14,987 — — 14,987
Reeve Emma Chief Financial Officer Feb 22 Open-market sale · S −6,260 $37.60 −$235K 0
Reeve Emma Chief Financial Officer Feb 22 Exercise / conversion · M +6,260 $8.04 +$50.3K 6,260
Reeve Emma Chief Financial Officer Feb 19 Open-market sale · S −4,010 $37.71 −$151K 0
Reeve Emma Chief Financial Officer Feb 19 Exercise / conversion · M +4,010 $8.04 +$32.2K 4,010
Reeve Emma Chief Financial Officer Feb 18 Open-market sale · S −1,100 $37.58 −$41.3K 0
Reeve Emma Chief Financial Officer Feb 18 Exercise / conversion · M +1,100 $8.04 +$8.84K 1,100
Column Group L P 10% owner Feb 17 Open-market sale · S −10,000 $36.95 −$370K 99,155
Column Group L P 10% owner Feb 17 Open-market sale · S −10,000 $36.95 −$370K 99,155
Reeve Emma Chief Financial Officer Feb 17 Exercise / conversion · M +410 $8.04 +$3.3K 410
Reeve Emma Chief Financial Officer Feb 17 Open-market sale · S −410 $37.56 −$15.4K 0
Valentine Karen See Remarks Jan 19 Open-market sale · S −7,203 $35.11 −$253K 0
Valentine Karen See Remarks Jan 19 Open-market sale · S −1,227 $33.69 −$41.3K 7,203
Valentine Karen See Remarks Jan 19 Open-market sale · S −8,773 $33.08 −$290K 8,430
Valentine Karen See Remarks Jan 19 Exercise / conversion · M +17,203 $11.50 +$198K 17,203
Goldsmith Mark A Director Dec 25 Gift · G −64,173 — — 74,870
Goldsmith Mark A Director Dec 21 Open-market sale · S −4,020 $35.02 −$141K 139,043

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support